Policy change impacting KPD eligibility coming Aug. 30
July 29, 2022
Changes to HLA and unacceptable antigen options will go into effect Aug. 30, as well as changes to the equivalences used for HLA matching and screening of unacceptable antigens between candidates and donors.
Updated National Liver Review Board guidance now in effect
July 27, 2022
Updates made to guidance for HCC and adult MELD exceptions.
Implementation notice: Requirement for race-neutral eGFR formulas in effect
July 27, 2022
Transplant hospitals are able to take immediate action to benefit a select population of Black candidates impacted by race-inclusive eGFR calculations.
Updates to living donor exclusion criteria now in effect
July 26, 2022
Four exclusion criteria in OPTN Policy 14.4.E have been updated to align with current research and guidelines as well as ensure consistency throughout OPTN policy language.
Two-year monitoring report summarizes National Liver Review Board activity
July 25, 2022
Report covers activity since the implementation of the acuity circles liver allocation policy.
COVID-19 update: July 21, 2022
July 21, 2022
New FDA announcements on Paxlovid and Novavax vaccine, Adjuvanted; Summer 2022 regional meetings to be in-person
Page 43 of 290
